Milestone Pharmaceuticals Announces Acceptance of Marketing Authorization Application for Etripamil Nasal Spray in PSVT by the European Medicines Agency GlobeNewswire January 06, 2026 European decision on approval is expected by Q1 2027 If approved, etripamil nasal spray is expected to offer patients a safe and effective self-administered treatment option for PSVT outside of the healthcare […]

Icon Energy Corp. Announces Reverse Stock Split GlobeNewswire January 06, 2026 ATHENS, Greece, Jan. 06, 2026 (GLOBE NEWSWIRE) — Icon Energy Corp. (“Icon” or the “Company“) (Nasdaq: ICON), an international shipping company providing worldwide seaborne transportation services for dry bulk cargoes via its fleet of oceangoing vessels, announced today that its board of directors (the

Terrestrial Energy Executes DOE Agreement for Project TETRA Under Advanced Reactor Pilot Program GlobeNewswire January 06, 2026 OTA agreement provides for construction and operation of Project TETRA, Terrestrial Energy's pilot reactor using Integral Molten Salt Reactor technology Terrestrial Energy now positioned to move quickly from design to operation under DOE authorization, laying the groundwork for

Provident Bank Annual Economic Outlook Survey: Business Owners Shift from Passive Optimism in 2025 to Active Investment in 2026 Findings reveal businesses are poised to accelerate, with significant projected increases in capital spending, hiring, and AI adoption GlobeNewswire January 06, 2026 ISELIN, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) — Provident Bank, a leading New Jersey-based

XBP Global Holdings, Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement GlobeNewswire January 06, 2026 IRVING, Texas, Jan. 06, 2026 (GLOBE NEWSWIRE) — XBP Global Holdings, Inc. (“XBP Global” or “the Company”) (NASDAQ: XBP), a workflow automation leader that leverages decades of industry experience, a global footprint, and agentic AI to rethink business process

Seismic Therapeutic Announces Updated Presentation Time at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 06, 2026 WATERTOWN, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) — Seismic Therapeutic, Inc., the machine learning immunology company, today announced an update to its presentation scheduled at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, California. Jo

Biolojic Design Appoints Roger Waltzman as Chief Medical Officer GlobeNewswire January 06, 2026 NESS ZIONA, Israel and WASHINGTON, Jan. 06, 2026 (GLOBE NEWSWIRE) — Biolojic Design, a biotechnology company that uses computational biology and artificial intelligence (AI) to transform antibodies into multifunctional, programmable medicines, today announced the appointment of Roger Waltzman as Chief Medical Officer.

CAMP4 to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 06, 2026 CAMBRIDGE, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) — CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein

Mineralys Therapeutics Provides Corporate Update and Announces Participation in Upcoming LifeSci Partners Corporate Access Event in January 2026 GlobeNewswire January 06, 2026 RADNOR, Pa., Jan. 06, 2026 (GLOBE NEWSWIRE) — Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension and related comorbidities such as chronic kidney disease (CKD),

Solid Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire January 06, 2026 CHARLESTOWN, Mass., Jan. 06, 2026 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company” or “Solid”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced that Bo Cumbo, President and CEO, will